Yes having listened to SH in that interview and read that WellBN link they certainly don’t have the same understanding of informed consent as I do.
informed consent is not “the patient wanted it so I provided it and they were happy”, it is a process that involves ensuring a patient knows and understands all the risks and intended benefits of a treatment before going ahead. In the field of gender medicine I don’t know how that can ever truly be the case, because there is so little long-term research. But certainly for children how can they possibly consent to anything like PBs when their brains aren’t developed enough to understand the implications of such a massive decision. It’s well-recognised that some decisions are simply too complex for Gillick competence to be valid. This is not the same kind of medicine as providing contraception or fixing a broken arm. Hence the ‘assent’ model in the Pathways trial.
This is why this should be specialist care - because the patient numbers are so small (for most practices, I understand that it is different at WellBN) that no regular GP will see enough of this to have the experience or expertise to prescribe independently. We have about 15,000 patients at my practice and fewer than 20 on the transgender register, not all of whom are prescribed any kind of hormone therapy. As GPs we are good at making sure they get appropriate screening invitations despite their gender marker being different from their sex. We are good at providing other general care. We should not, imo, be starting or supervising cross-sex hormones.